Serial changes in high‐sensitive troponin I predict outcome in patients with decompensated heart failure
Open Access
- 1 January 2011
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 13 (1), 37-42
- https://doi.org/10.1093/eurjhf/hfq210
Abstract
Aims The aim of this study was to evaluate the prognostic utility of small troponin I (TnI) elevations, serial TnI measurements, and the combination of TnI and brain natriuretic peptide (BNP) in patients with decompensated heart failure (HF). Methods and results One hundred and forty‐four patients with acute HF were followed from admission to 90 days post‐discharge. Primary endpoints were all cause mortality and HF‐related readmission. Troponin I and BNP levels were checked on admission, discharge, and up to four consecutive days during hospitalization. A discharge TnI cut‐off of 23.25 ng/L and discharge BNP cut‐off of 360 ng/L were determined by receiver operator characteristic (ROC). Troponin I above 23.25 ng/L is associated with increased risk for mortality and readmission (P = 0.003). Comparing with TnI quartile 1, TnI quartiles 2–4 had increased mortality and readmission, P = 0.019, P = 0.007, P = 0.014, respectively. Compared with patients with low TnI+low BNP, increased mortality and readmission were seen in patients with high TnI+high BNP (P = 0.007), high TnI+low BNP (P = 0.015), and low TnI+high BNP (P = 0.042). Patients with increasing TnI during treatment had increased mortality compared with patients with stable or decreasing TnI (P = 0.047). In multivariate analysis, TnI reached statistical significance (P = 0.009), while BNP did not. Conclusion This study demonstrates that very small TnI elevations and BNP elevations are associated with increased 90‐day mortality and readmission. When compared by ROC and multivariate analysis, TnI is as good a predictor of mortality and readmission as BNP if not slightly better. Patients with increasing TnI during hospitalization for acute HF had increased risk for 90‐day mortality.This publication has 17 references indexed in Scilit:
- Old and new biomarkers of heart failureEuropean Journal of Heart Failure, 2009
- Serial Sampling of ST2 Predicts 90-Day Mortality Following Destabilized Heart FailureJournal of Cardiac Failure, 2008
- Cardiac Troponin and Outcome in Acute Heart FailureThe New England Journal of Medicine, 2008
- Pro-B-Type Natriuretic Peptide Levels in Acute Decompensated Heart FailureJournal of the American College of Cardiology, 2008
- Analytical Relationships Among Biosite, Bayer, and Roche Methods for BNP and NT-proBNPAmerican Journal of Clinical Pathology, 2005
- Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunctionScandinavian Journal of Clinical and Laboratory Investigation, 2004
- Circulating concentrations of cardiac proteins indicate the severity of congestive heart failureHeart, 2003
- Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart FailureCirculation, 2003
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/ American College of Cardiology CommitteeJournal of the American College of Cardiology, 2000
- Cardiac Troponin-I: A Biochemical Marker for Cardiac Cell NecrosisDisease Markers, 1993